IDEA.L Regulatory News (IDEA)

14 April 2021

Ideagen PLC

("Ideagen," the "Company" or the "Group'')

Issue of new Shares under the Share Incentive Plan, PDMR Dealing & Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 3,386 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the purchase of 3,386 Ordinary Shares by a number of employees in aggregate under the Company's Share Incentive Plan ("SIP"). In addition, the Company has also applied for 2,213,333 Ordinary Shares to be admitted to trading on AIM. These shares were issued and allotted on 17 October 2019, and announced as such on that date, but the clerical procedures for ensuring admission to trading on AIM were not fully completed.

Application has been made to the London Stock Exchange for 3,386 new Ordinary Shares and 2,213,333 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 20 April 2021.

After Admission, the total number of Ordinary Shares in issue will be 252,298,765 and the total number of voting rights will therefore be 252,298,765. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

In addition to the above, Elizabeth Hewitt, the wife of Alex Hewitt, Chief Legal Officer, has sold 8,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at a price of 291 pence on 9 April 2021. Following the sale of shares, Mr Hewitt has a beneficiary interest in 108,095 shares, representing 0.05% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, more than 5,700 organisations use Ideagen's products including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .